Directory
>
Arthur Kuan
Arthur Kuan
Chairman and CEO | Moffitt Cancer Center
Irvine, California, United States
Arthur Kuan
Summary
Arthur Kuan is a dynamic leader and the Chairman and CEO of CG Oncology, where he steers innovative approaches in oncolytic immunotherapy aimed at improving the lives of urologic cancer patients. With a strong academic foundation in biotechnology from Johns Hopkins University and molecular biology from the University of Pennsylvania, he blends scientific expertise with business acumen. Arthur has built a diverse career across various sectors, including investment management and cancer research, showcasing his adaptability and strategic thinking. His experience spans significant roles in both startups and established organizations, reflecting a commitment to advancing healthcare solutions. Recognized as a Forbes 30 Under 30 honoree, Arthur embodies a blend of leadership and innovation in the life sciences arena. He is also multilingual, with proficiency in Mandarin, enhancing his business development efforts in China. Arthur's work is driven by a passion for transforming healthcare through technology and collaboration.
Arthur Kuan
Work Experience
Chairman and CEO at
CG Oncology
December 2023 - Present
IP Commercialization Strategy Committee Member at
Moffitt Cancer Center
November 2017 - Present
CEO and Director at
CG Oncology
September 2016 - December 2023
COO at
CG Oncology
July 2015 - September 2016
Founding Member at
Ally Bridge Group (pe) LLC
July 2013 - July 2015
Analyst at
Themes Investment Management Limited
February 2013 - June 2015
Analyst at
DNV CAPITAL (HK) LIMITED
July 2012 - February 2013
Arthur Kuan
Education
Johns Hopkins University, Master Of Science (M.S.)
University of Pennsylvania, Bachelor Of Arts (B.A.)
stevenson school
Frequently Asked Questions about Arthur Kuan
What is Arthur Kuan email address?
Arthur Kuan's primary email address is ***********@moffitt.org. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Arthur Kuan work for?
Arthur Kuan is a Chairman and CEO at Moffitt Cancer Center.
Where Arthur Kuan graduated from?
Arthur Kuan holds a degree in Biotechnology from Johns Hopkins University.
How can I directly contact Arthur Kuan?
To contact Arthur Kuan directly, you can use the email address ***********@moffitt.org. Complete contact information is available upon registration with Muraena.
Is Arthur Kuan an immigrant?
Yes, Arthur Kuan is an immigrant and currently based in United States
Who is Arthur Kuan?
Arthur Kuan is a dynamic leader and the Chairman and CEO of CG Oncology, where he steers innovative approaches in oncolytic immunotherapy aimed at improving the lives of urologic cancer patients. With a strong academic foundation in biotechnology from Johns Hopkins University and molecular biology from the University of Pennsylvania, he blends scientific expertise with business acumen. Arthur has built a diverse career across various sectors, including investment management and cancer research, showcasing his adaptability and strategic thinking. His experience spans significant roles in both startups and established organizations, reflecting a commitment to advancing healthcare solutions. Recognized as a Forbes 30 Under 30 honoree, Arthur embodies a blend of leadership and innovation in the life sciences arena. He is also multilingual, with proficiency in Mandarin, enhancing his business development efforts in China. Arthur's work is driven by a passion for transforming healthcare through technology and collaboration.
Arthur`s contact details
***********@moffitt.org
***********@aicgroup.com.tw
***********@cgoncology.com
***********@ally-bridge.com
***********@coldgenesys.com
Colleagues
EVP, Chief Operating Officer, Hospital President
Associate Vice President of Development Operations
Vice President, Foundation
Associate Chief Medical Information Officer (CMIO) for Pathology Informatics
Business Analyst
Chief Audit Officer
Vice President | Ambulatory, Ancillary, and Virtual Health Operations
Chief Resident, Department of Radiation Oncology
Chief Executive Officer Communications Manager